The effects of alcohol on coagulation and fibrinolytic factors: A controlled trial

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 1, 1998, Pages 39-45

  Dimmitt, S B ^a   Rakic, V ^a   Puddey, I B ^a   Baker, R ^b   Oostryck, R ^c   Adams, M J ^c   Chesterman, C N ^d   Burke, V ^a   Beilin, L J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c CURTIN UNIVERSITY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Alcohol; Factor VII; Fibrinogen; Lipids; Plasminogen activator inhibitor; Tissue plasminogen activator

Indexed keywords

ADULT; AGED; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; BEER; BLOOD CLOTTING; BRAIN BLOOD FLOW; CORONARY ARTERY BLOOD FLOW; FIBRINOLYSIS; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE;

EID: 0031942219     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199801000-00005     Document Type: Article

References (39)

1. Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988; 319: 267-273.
2. Jackson R, Scragg R, Beaglehole R. Alcohol consumption and risk of coronary heart disease. Br Med J 1991; 303: 211-216.
3. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, Stampfer MJ. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991; 338: 464-468.
4. Puddey IB, Beilin LJ, Vandongen R. Regular alcohol use raises blood pressure in treated hypertensive subjects. A randomised controlled trial. Lancet 1987; I: 647-651.
5. Masarei JRL, Puddey IB, Rouse IL, Lynch WJ, Vandongen R, Beilin LJ. Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations. Atherosclerosis 1986; 60: 79-87.
6. Cravo ML, Gloria LM, Selhub J, Nadeau MR, Camilo ME, Resende MP, et al. Hyperhomocysteinemia in chronic alcoholism - correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr 1996; 63: 220-224.
7. Knip M, Ekman A-C, Ekman M, Leppaluoto J, Vakkuri O. Ethanol induces a paradoxical simultaneous increase in circulating concentrations of insulin-like growth factor binding protein-1 and insulin. Metabolism 1995; 44: 1356-1359.
8. De Wood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902.
9. Solis OJ, Roberson GR, Taveras JM, Mohr J, Pessin M. Cerebral angiography in acute cerebral infarction. Revi Interam Radiol 1977; 2: 19-25.
10. Wilhelmsen L, Svardsudd K, Korsan-Bengsten K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505.
11. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-537.
12. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-59.
13. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-641.
14. Qizilbash N, Jones L, Warlow C, Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. Br Med J 1991; 303: 605-609.
15. Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey, 1989-1990. Arterioscler Thromb 1992; 12: 780-788.
16. Brunner EJ, Marmot MG, White IR, O'Brien JR, Etherington MD, Slavin BM, et al. Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study. Atherosclerosis 1993; 102: 195-207.
17. Rankinen T, Rauramaa R, Vaisanen S, Penttila IM, Uusitupa M. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors. Thromb Haemost 1994; 71: 180-183.
18. Pikaar NA, Wedel M, van der Beck EJ, van Dokkum W, Kempen HJM, Kluft C, et al. Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism 1987; 36: 538-543.
19. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-1079.
20. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-1168.
21. Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; ii: 3-9.
22. Iso H, Folsom AR, Koike KA, Sato S, Wu KK, Shimamoto T, et al. Antigens of tissue plasminogen activator and plasminogen activator inhibitor 1: correlates in nonsmoking Japanese and Caucasian men and women. Thromb Haemost 1993; 70: 475-480.
23. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994; 272: 929-933.
24. Veenstra J, Kluft C, Ockhuizen T, Pol Hvd, Wedel M, Schaafsma G. Effects of moderate alcohol consumption on platelet function, tissue-type plasminogen activator and plasminogen activator inhibitor. Thromb Haemost 1990; 63: 345-348.
25. Hendriks HFJ, Veenstra J, Velthuis-te Wierik EJM, Schaafsma G, Kluft C. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. Br Med J 1994; 308: 1003-1006.
26. Gill JS, Shipley MJ, Tsementzis SA, Hornby RS, Gill SK, Hitchcock ER, et al. Alcohol consumption-a risk factor for hemorrhagic and non-hemorrhagic stroke. Am J Med 1991; 90: 489-497.
27. Iso H, Folsom AR, Wu KK, Finch A, Munger RG, Sato S, et al. Hemostatic variables in Japanese and Caucasian men. Plasma fibrinogen, factor VIIc, factor VIIIc, and von Willebrand factor and their relations to cardiovascular disease risk factors. Am J Epidemiol 1989; 130: 925-934.
28. Hoffman CJ, Lawson WE, Miller RH, Hultin MB. Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1994; 14: 1737-1740.
29. Green D, Ruth KJ, Folsom AR, Liu K. Hemostatic factors in the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb 1994; 14: 686-693.
30. Mehrabian M, Peter JB, Barnard RJ, Lusis AJ. Dietary regulation of fibrinolytic factors. Atherosclerosis 1990; 84: 25-32.
31. Broze GJ. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Sem Haematol 1992; 29: 159-169.
32. Adams MJ, Dunstan RA, Oostryck R. Interference by lupus anticoagulant in a functional assay for tissue factor pathway inhibitor. Thromb Res 1995; 80: 435-440.
33. 2-glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant. Br J Haematol 1996; 93: 185-194.
34. Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol 1979; 8: 7-20.
35. Kannel WB, Wolf PA, Castelli WP, D'Agostino JB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987; 258: 1183-1186.
36. Fink R, Hutton RA. Changes in the blood platelets of alcoholics during alcohol withdrawal. J Clin Pathol 1983; 36: 337-340.
37. Mikhailidis DP, Barradas MA, Jeremy JY. The effect of ethanol on platelet function and vascular prostanoids. Alcohol 1990; 7: 171-180.
38. a and lipoproteins. Thromb Res 1987; 46: 527-537.
39. 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions. FEBS Letters 1979; 102: 183-186.